HK1197185A1 - Methods and compositions for treatment of epithelial wounds - Google Patents

Methods and compositions for treatment of epithelial wounds

Info

Publication number
HK1197185A1
HK1197185A1 HK14110749.7A HK14110749A HK1197185A1 HK 1197185 A1 HK1197185 A1 HK 1197185A1 HK 14110749 A HK14110749 A HK 14110749A HK 1197185 A1 HK1197185 A1 HK 1197185A1
Authority
HK
Hong Kong
Prior art keywords
compositions
treatment
methods
epithelial wounds
wounds
Prior art date
Application number
HK14110749.7A
Other languages
English (en)
Chinese (zh)
Inventor
Ian S Zagon
Patricia J Mclaughlin
Joseph W Sassani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1197185A1 publication Critical patent/HK1197185A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK14110749.7A 2011-07-28 2014-10-27 Methods and compositions for treatment of epithelial wounds HK1197185A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161512577P 2011-07-28 2011-07-28
PCT/US2012/048236 WO2013016480A1 (fr) 2011-07-28 2012-07-26 Procédés et compositions pour le traitement de plaies épithéliales

Publications (1)

Publication Number Publication Date
HK1197185A1 true HK1197185A1 (en) 2015-01-09

Family

ID=47601523

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14110749.7A HK1197185A1 (en) 2011-07-28 2014-10-27 Methods and compositions for treatment of epithelial wounds

Country Status (9)

Country Link
US (2) US9283175B2 (fr)
EP (1) EP2736512B1 (fr)
JP (1) JP6072789B2 (fr)
CN (1) CN103826635A (fr)
AU (1) AU2012286843A1 (fr)
CA (1) CA2842337C (fr)
HK (1) HK1197185A1 (fr)
IL (1) IL230672B (fr)
WO (1) WO2013016480A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103826635A (zh) * 2011-07-28 2014-05-28 伊恩.S.扎冈 治疗上皮创伤的方法和组合物
WO2014112955A1 (fr) * 2013-01-21 2014-07-24 Bigliardi Paul Utilisation d'antagonistes sélectifs du récepteur delta-opioïde et ligands spécifiques de récepteurs sensoriels
US20220047590A1 (en) * 2019-04-11 2022-02-17 Cmpd Licensing, Llc Wound treatments and compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266574A (en) 1984-04-09 1993-11-30 Ian S. Zagon Growth regulation and related applications of opioid antagonists
US5834480A (en) * 1997-06-13 1998-11-10 Elkhoury; George F. Topical application of opioids for treatment of acne and sebaceous gland disorders
CA2522471A1 (fr) 2003-04-14 2004-10-28 Pain Therapeutics, Inc. Procedes et materiaux de traitement des douleurs comprenant des antagonistes opioides
CN101850108A (zh) * 2003-07-15 2010-10-06 巴尔-伊兰大学 用于愈合创伤的方法和药物组合物
EP1926490A2 (fr) * 2005-09-23 2008-06-04 DSMIP Assets B.V. Utilisation d'antagonistes du recepteur opioide
US7939567B2 (en) * 2006-02-24 2011-05-10 Blue Blood Biotech Corp. Dextromethorphan-based method for treating acne
WO2008073653A2 (fr) * 2006-11-08 2008-06-19 Zymogenetics, Inc. Procédés d'utilisation de l'il-17b
WO2009120889A2 (fr) 2008-03-26 2009-10-01 Alltranz Inc. Formulations transdermiques inviolables d’agonistes et d’agonistes-antagonistes d’opiacés
GB0808751D0 (en) * 2008-05-14 2008-06-18 Serentis Ltd Topical compositions of opioid compound for use in wound healing
MX370599B (es) * 2008-08-15 2019-12-18 Boehringer Ingelheim Int Derivados de purina para su uso en el tratamiento de enfermedades relacionadas con fab.
TR201203732T1 (tr) 2009-10-01 2012-09-21 Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş. Opioid antagonistlerin topikal bileşimleri ve deri hastalıklarının bu bileşimler ile tedavisi için yöntemler.
CN103826635A (zh) * 2011-07-28 2014-05-28 伊恩.S.扎冈 治疗上皮创伤的方法和组合物

Also Published As

Publication number Publication date
US9974783B2 (en) 2018-05-22
EP2736512A1 (fr) 2014-06-04
IL230672A0 (en) 2014-03-31
IL230672B (en) 2019-03-31
CA2842337C (fr) 2020-02-18
US9283175B2 (en) 2016-03-15
AU2012286843A1 (en) 2014-02-20
EP2736512B1 (fr) 2021-06-30
US20140171460A1 (en) 2014-06-19
EP2736512A4 (fr) 2015-04-29
US20160250206A1 (en) 2016-09-01
JP6072789B2 (ja) 2017-02-01
JP2014521650A (ja) 2014-08-28
WO2013016480A1 (fr) 2013-01-31
CN103826635A (zh) 2014-05-28
CA2842337A1 (fr) 2013-01-31

Similar Documents

Publication Publication Date Title
EP2771030A4 (fr) Compositions et méthodes de traitement de protéinopathies
EP2776567A4 (fr) Compositions et méthodes pour le traitement d'infections par cytomégalovirus
EP2603202A4 (fr) Compositions et méthodes pour traiter une tauopathie
EP2684167A4 (fr) Compositions et méthodes utiles dans le traitement de maladies
HK1258530A1 (zh) Serpina 1 sirnas:物質的組合物和治療方法
PL2740796T3 (pl) Kompozycja farmaceutyczna do leczenia nowotworu i/lub zapobiegania nowotworowi
EP2740794A4 (fr) Composition pharmaceutique destinée à traiter ou à prévenir le cancer
HK1198012A1 (zh) 用於治療瘻的組合物
HK1200086A1 (en) Methods and compositions relating to p62 for the treatment and prophylaxis of cancer p62
EP2773212A4 (fr) Méthodes et compositions utilisées pour le traitement de l'autisme
EP2688594A4 (fr) Procédés et compositions pour le traitement du cancer
HK1199015A1 (en) Treatment of inflammation
EP2696874A4 (fr) Compositions et méthodes utilisées de traitement d'affections nasales
DK3292875T3 (en) Compositions and methods for treating diseases
EP2788012A4 (fr) Compositions et méthodes de traitement de maladies rénales
EP2755668A4 (fr) Compositions dérivées de hyr1 et méthodes de traitement les utilisant
EP2696693A4 (fr) Composition et procédés pour le traitement de polymères contre l'encrassement macroscopique
EP2670243A4 (fr) Compositions et procédés pour le traitement du glaucome
EP2549867A4 (fr) Compositions et procédés pour la prévention et le traitement de blessures
HK1197185A1 (en) Methods and compositions for treatment of epithelial wounds
EP2928456A4 (fr) Procédés et compositions pour le traitement du cancer
EP2825184A4 (fr) Compositions et méthodes pour le traitement de la douleur
EP2685820A4 (fr) Compositions et méthodes de traitement d'infections
ZA201107399B (en) Method and compositions for treatment of cancer
AU2011902129A0 (en) Compositions for Therapy and Methods of Treatment